Regeneron Pharmaceuticals Inc (REGN)

783.13
+31.93(+4.25%)
After Hours
783.71
+0.58(+0.07%)
- Real-time Data
  • Volume:
    1,444,152
  • Day's Range:
    758.63 - 789.95
  • 52 wk Range:
    538.01 - 789.95
Unusual trading volume

Regeneron Pharma has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

1 / 2

REGN Overview

Prev. Close
751.2
Day's Range
758.63-789.95
Revenue
8.76B
Open
764.49
52 wk Range
538.01-789.95
EPS
50.2
Volume
1,444,152
Market Cap
83.64B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
649,115
P/E Ratio
15.68
Beta
0.206
1-Year Change
25.71%
Shares Outstanding
106,801,935
Next Earnings Date
May 04, 2023
What is your sentiment on Regeneron Pharma?
or
Market is currently closed. Voting is open during market hours.

Regeneron Pharmaceuticals Inc News

Regeneron Pharmaceuticals Inc Analysis

Regeneron Pharmaceuticals Inc Company Profile

Regeneron Pharmaceuticals Inc Company Profile

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.

Read More

Analyst Price Target

Average816.35 (+4.24% Upside)
High1,023.00
Low605.00
Price783.13
No. of Analysts23
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong SellBuyStrong BuyStrong BuyStrong Buy
SummaryStrong SellBuyStrong BuyStrong BuyStrong Buy
  • hiw does a stock get to be 800 dollars a share
    0
    • REGN Earnings are wrong !!! it was 3.41B not M
      0
      • Falling knife
        1
        • I want your ******
          0
      • 😃
        0
        • best opportunity in this market
          1
          • only take long positions .
            0
            • huge earnings beat!
              0
              • Whats happening
                0
                • Fall
                  0
                • Most of sales in this quarters are from COVID, and competion announced results
                  0
              • Acquiring Inovio will propel REGN closer to COVID 19 vaccine and clear path to 1K a share.
                3
                • This should boost Inovio. Time to pile up.
                  2